Justification of local anesthetic and choice of its concentration in composition of dental gel

Dental diseases are often accompanied by painful sensations, so usually symptomatic treatment of these pathologies includes local anesthetics, as which we have selected anesthetic of local action – lidocaine hydrochloride. The aim of the research is to substantiate the rational concentration of l...

Full description

Bibliographic Details
Main Authors: Yu. S. Maslii, O. О. Hrudnytska, O. A. Ruban, G. V. Zaychenko
Format: Article
Language:Ukrainian
Published: The State Expert Center of the Ministry of Health of Ukraine 2019-07-01
Series:Фармацевтичний журнал
Subjects:
Online Access:https://pharmj.org.ua/index.php/journal/article/view/604/569
_version_ 1817990158776008704
author Yu. S. Maslii
O. О. Hrudnytska
O. A. Ruban
G. V. Zaychenko
author_facet Yu. S. Maslii
O. О. Hrudnytska
O. A. Ruban
G. V. Zaychenko
author_sort Yu. S. Maslii
collection DOAJ
description Dental diseases are often accompanied by painful sensations, so usually symptomatic treatment of these pathologies includes local anesthetics, as which we have selected anesthetic of local action – lidocaine hydrochloride. The aim of the research is to substantiate the rational concentration of lidocaine hydrochloride in the composition of the dental gel being developed by pharmacological screening of its model samples. The object of the study is dental gel with tincture "Phytodent" (PJSC “CPP “Red Star”, Ukraine), choline salicylate 80% (Basf Pharma, Switzerland) and lidocaine hydrochloride (Societa Italiana Medicinali Scandicci, Italy). The anesthetic was injected into the gel at various concentrations – 1.0%, 1.5% and 2.0%. The study of local anesthetic/analgesic activity of gel test samples was performed by the Randall-Selitto method using an electronic Pressure Analgesiometer (IITC Life Science, USA). The study was conducted on male rats weighing 190–210 g. The animals were divided into three groups: animals of the 1st group were applied with 2.0% lidocaine hydrochloride gel (sample number 1), the second group – with 1.5% concentration (sample number 2), the third group – with 1.0% lidocaine content (sample number 3). The animal was held in the hands of a researcher, its limb was placed in analgesiometer. Determined the force of pressure in grams, which causes the reaction of the paw pull back / squeal in response to a painful stimulus. Analgesic activity was studied on the model of kaolin edema, which was simulated by sub-planar introduction of kaolin solution (10 mg/ml) in the amount of 0.1 ml/100 grams of body weight (administration under the aponeurosis of the posterior paw). In animals, the initial pain sensitivity was evaluated 1 hour after the introduction of the phlogogenic agent, after which the gel was applied to the foot, and in 1 hour 15 minutes, 1 hour 30 minutes and 2 hours after the exudative edema modelling. Calculated the percentage of change to the initial threshold of tactile sensitivity, as well as the percentage of change to the level of algesia (pain response) 1 hour after the introduction of the phlogogenic agent. Statistical processing of the data was performed using Student's t-criterion. According to the results, pronounced pain syndrome was detected in animals of all three groups 1 hour after the introduction of the phlogogenic agent. The use of gel with 1.0% concentration of lidocaine hydrochloride did not show a significant antinociceptive effect and could be considered as a tendency for analgesia. The pronounced local anesthetic effect was observed with the use of gel test specimens with the anesthetic concentrations of 1.5% and 2.0% after 15 and 30 minutes and lasted for at least 2 hours. The drug developed was compared with the dental gel “Kamistad®” (Stada Arzneimittel AG, Germany), which also contains lidocaine hydrochloride in an amount of 2.0%. Taking into account the fact that reliable statistical differences in the severity of analgesic activity between the test samples of gel number 1 and number 2 were not detected, it can be argued that lower lidocaine concentration 1.5% in the composition of the developed dental gel can be used. In addition, the claimed dental gel exceeded the referent drug "Kamistad®" (Stada Arzneimittel AG, Germany) by the expressiveness of antinociceptive effect.
first_indexed 2024-04-14T00:55:11Z
format Article
id doaj.art-1d4c940437fe4c35bf5a953db40b3a88
institution Directory Open Access Journal
issn 0367-3057
2617-9628
language Ukrainian
last_indexed 2024-04-14T00:55:11Z
publishDate 2019-07-01
publisher The State Expert Center of the Ministry of Health of Ukraine
record_format Article
series Фармацевтичний журнал
spelling doaj.art-1d4c940437fe4c35bf5a953db40b3a882022-12-22T02:21:37ZukrThe State Expert Center of the Ministry of Health of UkraineФармацевтичний журнал0367-30572617-96282019-07-0133495510.32352/0367-3057.3.19.06Justification of local anesthetic and choice of its concentration in composition of dental gelYu. S. Maslii0O. О. Hrudnytska1O. A. Ruban2G. V. Zaychenko3National University of Pharmacy, KharkivBogomolets National Medical University, KуivNational University of Pharmacy, KharkivBogomolets National Medical University, KуivDental diseases are often accompanied by painful sensations, so usually symptomatic treatment of these pathologies includes local anesthetics, as which we have selected anesthetic of local action – lidocaine hydrochloride. The aim of the research is to substantiate the rational concentration of lidocaine hydrochloride in the composition of the dental gel being developed by pharmacological screening of its model samples. The object of the study is dental gel with tincture "Phytodent" (PJSC “CPP “Red Star”, Ukraine), choline salicylate 80% (Basf Pharma, Switzerland) and lidocaine hydrochloride (Societa Italiana Medicinali Scandicci, Italy). The anesthetic was injected into the gel at various concentrations – 1.0%, 1.5% and 2.0%. The study of local anesthetic/analgesic activity of gel test samples was performed by the Randall-Selitto method using an electronic Pressure Analgesiometer (IITC Life Science, USA). The study was conducted on male rats weighing 190–210 g. The animals were divided into three groups: animals of the 1st group were applied with 2.0% lidocaine hydrochloride gel (sample number 1), the second group – with 1.5% concentration (sample number 2), the third group – with 1.0% lidocaine content (sample number 3). The animal was held in the hands of a researcher, its limb was placed in analgesiometer. Determined the force of pressure in grams, which causes the reaction of the paw pull back / squeal in response to a painful stimulus. Analgesic activity was studied on the model of kaolin edema, which was simulated by sub-planar introduction of kaolin solution (10 mg/ml) in the amount of 0.1 ml/100 grams of body weight (administration under the aponeurosis of the posterior paw). In animals, the initial pain sensitivity was evaluated 1 hour after the introduction of the phlogogenic agent, after which the gel was applied to the foot, and in 1 hour 15 minutes, 1 hour 30 minutes and 2 hours after the exudative edema modelling. Calculated the percentage of change to the initial threshold of tactile sensitivity, as well as the percentage of change to the level of algesia (pain response) 1 hour after the introduction of the phlogogenic agent. Statistical processing of the data was performed using Student's t-criterion. According to the results, pronounced pain syndrome was detected in animals of all three groups 1 hour after the introduction of the phlogogenic agent. The use of gel with 1.0% concentration of lidocaine hydrochloride did not show a significant antinociceptive effect and could be considered as a tendency for analgesia. The pronounced local anesthetic effect was observed with the use of gel test specimens with the anesthetic concentrations of 1.5% and 2.0% after 15 and 30 minutes and lasted for at least 2 hours. The drug developed was compared with the dental gel “Kamistad®” (Stada Arzneimittel AG, Germany), which also contains lidocaine hydrochloride in an amount of 2.0%. Taking into account the fact that reliable statistical differences in the severity of analgesic activity between the test samples of gel number 1 and number 2 were not detected, it can be argued that lower lidocaine concentration 1.5% in the composition of the developed dental gel can be used. In addition, the claimed dental gel exceeded the referent drug "Kamistad®" (Stada Arzneimittel AG, Germany) by the expressiveness of antinociceptive effect.https://pharmj.org.ua/index.php/journal/article/view/604/569dental gellidocaine hydrochloridelocal anesthetic activity
spellingShingle Yu. S. Maslii
O. О. Hrudnytska
O. A. Ruban
G. V. Zaychenko
Justification of local anesthetic and choice of its concentration in composition of dental gel
Фармацевтичний журнал
dental gel
lidocaine hydrochloride
local anesthetic activity
title Justification of local anesthetic and choice of its concentration in composition of dental gel
title_full Justification of local anesthetic and choice of its concentration in composition of dental gel
title_fullStr Justification of local anesthetic and choice of its concentration in composition of dental gel
title_full_unstemmed Justification of local anesthetic and choice of its concentration in composition of dental gel
title_short Justification of local anesthetic and choice of its concentration in composition of dental gel
title_sort justification of local anesthetic and choice of its concentration in composition of dental gel
topic dental gel
lidocaine hydrochloride
local anesthetic activity
url https://pharmj.org.ua/index.php/journal/article/view/604/569
work_keys_str_mv AT yusmaslii justificationoflocalanestheticandchoiceofitsconcentrationincompositionofdentalgel
AT oohrudnytska justificationoflocalanestheticandchoiceofitsconcentrationincompositionofdentalgel
AT oaruban justificationoflocalanestheticandchoiceofitsconcentrationincompositionofdentalgel
AT gvzaychenko justificationoflocalanestheticandchoiceofitsconcentrationincompositionofdentalgel